LISATA THERAPEUTICS INC (LSTA) Stock Price & Overview
NASDAQ:LSTA • US1280583022
Current stock price
The current stock price of LSTA is 5.02 USD. Today LSTA is up by 0.2%. In the past month the price increased by 18.68%. In the past year, price increased by 152.26%.
LSTA Key Statistics
- Market Cap
- 45.331M
- P/E
- N/A
- Fwd P/E
- N/A
- EPS (TTM)
- -1.91
- Dividend Yield
- N/A
LSTA Stock Performance
LSTA Stock Chart
LSTA Technical Analysis
ChartMill assigns a technical rating of 9 / 10 to LSTA. When comparing the yearly performance of all stocks, LSTA is one of the better performing stocks in the market, outperforming 97.72% of all stocks.
LSTA Fundamental Analysis
ChartMill assigns a fundamental rating of 2 / 10 to LSTA. While LSTA seems to be doing ok healthwise, there are quite some concerns on its profitability.
LSTA Earnings
LSTA Forecast & Estimates
9 analysts have analysed LSTA and the average price target is 11.56 USD. This implies a price increase of 130.28% is expected in the next year compared to the current price of 5.02.
LSTA Groups
Sector & Classification
LSTA Financial Highlights
Over the last trailing twelve months LSTA reported a non-GAAP Earnings per Share(EPS) of -1.91. The EPS increased by 20.31% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -93.47% | ||
| ROE | -111.65% | ||
| Debt/Equity | 0 |
LSTA Ownership
LSTA Competitors/Peers
| Symbol | Company Name | Technical Rating | Fundamental Rating | FPE | Market Cap |
|---|---|---|---|---|---|
| ABBV | ABBVIE INC | 14.07 | 369.265B | ||
| AMGN | AMGEN INC | 15.24 | 187.564B | ||
| GILD | GILEAD SCIENCES INC | 15.81 | 173.439B | ||
| VRTX | VERTEX PHARMACEUTICALS INC | 22.63 | 111.445B | ||
| REGN | REGENERON PHARMACEUTICALS | 16.3 | 80.543B | ||
| ALNY | ALNYLAM PHARMACEUTICALS INC | 42.73 | 42.286B | ||
| INSM | INSMED INC | N/A | 35.012B | ||
| NTRA | NATERA INC | N/A | 29.477B | ||
| BIIB | BIOGEN INC | 11.03 | 26.026B | ||
| UTHR | UNITED THERAPEUTICS CORP | 18.91 | 24.756B | ||
| RVMD | REVOLUTION MEDICINES INC | N/A | 19.643B | ||
| MRNA | MODERNA INC | N/A | 19.431B | ||
| INCY | INCYTE CORP | 12.53 | 19.091B |
Related stock screener links
View all stocks in the Biotechnology Industry | View all stocks in the Health Care Sector | View all stocks on the Nasdaq Exchange | Find stocks with similar TA and Setup ratings on the USA exchanges | Find stocks with similar Fundamental rating on the USA exchanges | Find the competitors with the best technical ratings on the USA exchanges | Find the competitors with the best fundamentals on the USA exchanges | Find the competitors with the best valuation on the USA exchanges | Find the competitors with the best dividend on the USA exchanges | Find the competitors with the best analyst ratings on the USA exchanges
About LSTA
Company Profile
Lisata Therapeutics, Inc. is a clinical-stage pharmaceutical company, which engages in the discovery, development, and commercialization of innovative therapies for the treatment of solid tumors and other major diseases. The company is headquartered in Basking Ridge, New Jersey and currently employs 21 full-time employees. The Company’s cyclic peptide product candidate, certepetide, is an investigational drug designed to activate a novel uptake pathway that allows co-administered or tethered anti-cancer drugs to selectively target and penetrate solid tumors more effectively. Certepetide actuates this active transport system in a tumor-specific manner, resulting in systemically co-administered anti-cancer drugs penetrating and accumulating in the tumor, while normal tissues are expected to remain unaffected. The Company’s investigational drug candidate from the CendR Platform, certepetide, holds broader potential to be combined as a co-administration treatment with an array of anti-cancer and diagnostic agents to benefit solid tumor cancer patients.
Company Info
IPO: 1995-11-03
LISATA THERAPEUTICS INC
110 Allen Road, Second Floor
Basking Ridge NEW JERSEY US
Employees: 26
Phone: 19082292590
LISATA THERAPEUTICS INC / LSTA FAQ
What does LISATA THERAPEUTICS INC do?
Lisata Therapeutics, Inc. is a clinical-stage pharmaceutical company, which engages in the discovery, development, and commercialization of innovative therapies for the treatment of solid tumors and other major diseases. The company is headquartered in Basking Ridge, New Jersey and currently employs 21 full-time employees. The Company’s cyclic peptide product candidate, certepetide, is an investigational drug designed to activate a novel uptake pathway that allows co-administered or tethered anti-cancer drugs to selectively target and penetrate solid tumors more effectively. Certepetide actuates this active transport system in a tumor-specific manner, resulting in systemically co-administered anti-cancer drugs penetrating and accumulating in the tumor, while normal tissues are expected to remain unaffected. The Company’s investigational drug candidate from the CendR Platform, certepetide, holds broader potential to be combined as a co-administration treatment with an array of anti-cancer and diagnostic agents to benefit solid tumor cancer patients.
What is the current price of LSTA stock?
The current stock price of LSTA is 5.02 USD. The price increased by 0.2% in the last trading session.
Does LSTA stock pay dividends?
LSTA does not pay a dividend.
What is the ChartMill rating of LISATA THERAPEUTICS INC stock?
LSTA has a ChartMill Technical rating of 9 out of 10 and a ChartMill Fundamental rating of 2 out of 10.
Where is LISATA THERAPEUTICS INC (LSTA) stock traded?
LSTA stock is listed on the Nasdaq exchange.
Can you provide the sector and industry classification for LISATA THERAPEUTICS INC?
LISATA THERAPEUTICS INC (LSTA) operates in the Health Care sector and the Biotechnology industry.
Is LISATA THERAPEUTICS INC (LSTA) stock a good buy?
This depends on your investment goals. Check the Technical and Fundamental Analysis tabs for insights on LSTA.